HWAM
Hennion & Walsh Asset Management’s Atara Biotherapeutics ATRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-119,051
| Closed | -$82.6K | – | 843 |
|
|
2024
Q1 | $82.6K | Buy |
119,051
+7,923
| +7% | +$5.5K | ﹤0.01% | 836 |
|
|
2023
Q4 | $57K | Sell |
111,128
-57,788
| -34% | -$29.6K | ﹤0.01% | 815 |
|
|
2023
Q3 | $250K | Sell |
168,916
-10,221
| -6% | -$15.1K | 0.02% | 695 |
|
|
2023
Q2 | $288K | Sell |
179,137
-90,009
| -33% | -$145K | 0.02% | 660 |
|
|
2023
Q1 | $781K | Sell |
269,146
-8,055
| -3% | -$23.4K | 0.05% | 409 |
|
|
2022
Q4 | $909K | Buy |
277,201
+30,818
| +13% | +$101K | 0.06% | 364 |
|
|
2022
Q3 | $931K | Buy |
246,383
+17,851
| +8% | +$67.5K | 0.06% | 341 |
|
|
2022
Q2 | $1.78M | Buy |
228,532
+71,973
| +46% | +$561K | 0.11% | 217 |
|
|
2022
Q1 | $1.45M | Buy |
156,559
+31,048
| +25% | +$288K | 0.08% | 270 |
|
|
2021
Q4 | $1.98M | Buy |
125,511
+50,052
| +66% | +$789K | 0.1% | 236 |
|
|
2021
Q3 | $1.35M | Buy |
75,459
+25,828
| +52% | +$462K | 0.07% | 295 |
|
|
2021
Q2 | $772K | Buy |
49,631
+24,177
| +95% | +$376K | 0.04% | 419 |
|
|
2021
Q1 | $366K | Buy |
+25,454
| New | +$366K | 0.02% | 553 |
|